{
    "Symbol": "RVTY",
    "AssetType": "Common Stock",
    "Name": "Revvity Inc.",
    "Description": "Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets globally. The company is headquartered in Waltham, Massachusetts.",
    "CIK": "31791",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "LABORATORY ANALYTICAL INSTRUMENTS",
    "Address": "940 WINTER STREET, WALTHAM, MA, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "15210655000",
    "EBITDA": "780210000",
    "PERatio": "77.04",
    "PEGRatio": "1.961",
    "BookValue": "63.74",
    "DividendPerShare": "0.28",
    "DividendYield": "0.0022",
    "EPS": "1.6",
    "RevenuePerShareTTM": "21.93",
    "ProfitMargin": "0.0626",
    "OperatingMarginTTM": "0.156",
    "ReturnOnAssetsTTM": "0.0159",
    "ReturnOnEquityTTM": "0.0251",
    "RevenueTTM": "2708245000",
    "GrossProfitTTM": "2040719000",
    "DilutedEPSTTM": "1.6",
    "QuarterlyEarningsGrowthYOY": "0.579",
    "QuarterlyRevenueGrowthYOY": "-0.025",
    "AnalystTargetPrice": "136.27",
    "AnalystRatingStrongBuy": "4",
    "AnalystRatingBuy": "7",
    "AnalystRatingHold": "8",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "77.04",
    "ForwardPE": "23.04",
    "PriceToSalesRatioTTM": "4.862",
    "PriceToBookRatio": "1.689",
    "EVToRevenue": "5.71",
    "EVToEBITDA": "21.64",
    "Beta": "1.054",
    "52WeekHigh": "128.15",
    "52WeekLow": "79.34",
    "50DayMovingAverage": "110.18",
    "200DayMovingAverage": "103.72",
    "SharesOutstanding": "123393000",
    "DividendDate": "2024-11-08",
    "ExDividendDate": "2024-10-18"
}